42 participants
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-12-04
- Start Date:
- 2019-01-29
- Completion:
- 2023-10-12
Conditions
- B-cell Lymphoma
Interventions
- BIOLOGICAL
- DRUG